Theoretical aspects of autism: Biomarkersa review

Journal of Immunotoxicology

Volumn 8, Issue 1, 2011, Pages 80-94

  Ratajczak, Helen V ^a  

^a NONE

Author keywords

amino acids; Autism; autism spectrum disorder; hormones; metabolites; objective measure of autism; pervasive developmental disorder

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; B LYMPHOCYTE ANTIBODY; BETA ENDORPHIN; BIOLOGICAL MARKER; BIOPTERIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; COPROPORPHYRIN; CORTICOTROPIN; CYCLIC AMP; DELTORPHIN; DERMORPHIN; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DISACCHARIDASE; GAMMA INTERFERON; GLIADIN ANTIBODY; GLUTAMIC ACID; HYDROCORTISONE; IMMUNOGLOBULIN A; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELATONIN; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SULFATE; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

AUTISM; DETOXIFICATION; DISEASE SEVERITY; GASTROINTESTINAL TRACT; HUMAN; IMMUNE SYSTEM; NEUROPATHOLOGY; OXIDATIVE STRESS; PINEAL GLAND FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW;

AMINO ACIDS; AUTISTIC DISORDER; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CYCLIC AMP; GASTROINTESTINAL DISEASES; HUMANS; OXIDATIVE STRESS; PEPTIDES; PINEAL GLAND;

EID: 79751493937     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.3109/1547691X.2010.538749     Document Type: Review

References (169)

1. 80-94 Ahloulay, M., Déchaux, M., Hassler, C., Bouby, N. and Bankir, L. 1996. Cyclic AMP is a hepatorenal link infuencing natriuresis and contributing to glucagon-induced hyperfltration in rats. J. Clin. Invest. 98:2251-2258. (Pubitemid 26394198)
2. Aldred, S., Moore, K.M., Fitzgerald, M. and Waring, R.H. 2003. Plasma amino acid levels in children with autism and their families. J. Autism Dev. Disord. 33:93-97. (Pubitemid 36323144)
3. Anderson, C. 2010. Careful counting: How many people have an ASD? Available at: www.iancommunity.org/cs/understanding-research/prevalence (March 2, 2010).
4. Arnold, G.L., Hyman, S.L., Mooney, R.A. and Kirby, R.S. 2003. Plasma amino acids profles in children with autism: potential risk of nutritional defciencies. J. Autism Dev. Disord. 33:449-454. (Pubitemid 37127941)
5. Auyeung, B., Baron-Cohen, S., Ashwin, E., Knickmeyer, R., Taylor, K. and Hackett, G. 2009. Fetal testosterone and autistic traits. Br. J. Psychol. 100:1-22.
6. Axelrod, J. 1974. Te pineal gland: a neurochemical transducer. Science. 184:1341-1348.
7. Axt, A. 1996. Autism viewed as a consequence of pineal gland malfunction. Farmakoter. Psychiat Neuro. 8:112-134.
8. Bannon, A.W., Decker, M.W., Holladay, M.W., Curzon, P, Donnelly-Roberts, D., Puttfarcken, PS., Bitner, R.S., Diaz, A., Dickenson, A.H., Porsolt, R.D., Williams, M. and Arneric, S.P 1998. Broad-spectrum, non-opioid anal-gesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:77-81. (Pubitemid 28079158)
9. Bauman, M.L. and Kemper, T.L. (Eds.) 1994. Neuroanatomic observations of the brain in autism. In: Te Neurobiology of Autism. Baltimore: Johns Hopkins University Press, pp. 119-145.
10. Bauman, M.L. and Kemper, T.L. 2005. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23:183-187. (Pubitemid 40313551)
11. Belmonte, M.K., Cook, E.H. Jr, Anderson, G.M., Rubenstein, J.L., Greenough, W.T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L.M., Powell, S.B., Levitt, PR., Perry, E.K., Jiang, Y.H., DeLorey, T.M. and Tierney, E. 2004. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol. Psychiatry. 9:646-663. (Pubitemid 38932171)
12. Binstock, T. 2001. Intra-monocyte pathogens delineate autism subgroups. Med. Hypotheses. 56:523-531. (Pubitemid 32397890)
13. Blatt, G.J., Fitzgerald, C.M., Guptill, J.T., Booker, A.B., Kemper, T.L. and Bauman, M.L. 2001. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord. 31:537-543. (Pubitemid 37490148)
14. Blaylock, R.L. and Strunecka, A. 2009. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr. Med. Chem. 16:157-170.
15. Brainard, G.C. 1978. Pineal research: the decade of transformation. J. Neural Transm. Suppl. 3-10.
16. Buller, K.M. and Day, T.A. 2002. Systemic administration of interleukin-1beta activates select populations of central amygdala aferents. J. Comp. Neurol. 452:288-296.
17. Burgess, N.K., Sweeten, T.L., McMahon, W.M. and Fujinami, R.S. 2006. Hyperserotoninemia and altered immunity in autism. J. Autism Dev. Disord. 36:697-704. (Pubitemid 44336992)
18. Carlsson, M.L. 1998. Hypothesis: is infantile autism a hypoglutamatergic dis-order? Relevance of glutamate-serotonin interactions for pharmaco-therapy. J. Neural Transm. 105:525-535. (Pubitemid 28365035)
19. Cass, H., Gringras, P., March, J., McKendrick, I., O'Hare, A.E., Owen, L. and Pollin, C. 2008. Absence of urinary opioid peptides in children with autism. Arch. Dis. Child. 93:745-750.
20. Cazzullo, A.G., Musetti, M.C., Musetti, L., Bajo, S., Sacerdote, P. and Panerai, A. 1999. Beta-endorphin levels in peripheral blood mononu-clear cells and long-term naltrexone treatment in autistic children. Eur. Neuropsychopharmacol. 9:361-366. (Pubitemid 29253789)
21. Chauhan, A. and Chauhan, V 2006. Oxidative stress in autism. Pathophysiology. 13:171-181.
22. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Grifth, E.C., Jaenisch, R. and Greenberg, M.E. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 302:885-889. (Pubitemid 37339632)
23. Cheng, L., Ge, Q., Xiao, P, Sun, B., Ke, X., Bai, Y. and Lu, Z. 2009. Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray. Int. J. Mol Sci. 10:2487-2500.
24. Chugani, D.C., Muzik, O., Behen, M., Rothermel, R., Janisse, J.J., Lee, J. and Chugani, H.T. 1999. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45:287-295. (Pubitemid 29120032)
25. Connolly, A.M., Chez, M., Streif, E.M., Keeling, R.M., Golumbek, PT., Kwon, J.M., Riviello, J.J., Robinson, R.G., Neuman, RJ. and Deuel, R.M. 2006. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Klefner syn-drome, and epilepsy. Biol. Psychiatry. 59:354-363. (Pubitemid 43238361)
26. Corbett, B.A., Mendoza, S., Abdullah, M., Wegelin, J.A. and Levine, S. 2006. Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology. 31:59-68. (Pubitemid 41668895)
27. Corbett, B.A., Mendoza, S., Wegelin, J.A., Carmean, V and Levine, S. 2008. Variable cortisol circadian rhythms in children with autism and antici-patory stress. J. Psychiatry Neurosci. 33:227-234. (Pubitemid 351692422)
28. Curin, J.M., Terzic, J., Petkovic, Z.B., Zekan, L., Terzic, I.M. and Susnjara, I.M. 2003. Lower cortisol and higher ACTH levels in individuals with autism. J. Autism Dev. Disord. 33:443-448. (Pubitemid 37127940)
29. Davis, M., Rainnie, D. and Cassell, M. 1994. Neurotransmission in the rat amy-gdala related to fear and anxiety. Trends Neurosci. 17:208-214. (Pubitemid 24128464)
30. DeLorey, T.M., Handforth, A., Anagnostaras, S.G., Homanics, G.E., Minassian, B.A., Asatourian, A., Fanselow, M.S., Delgado-Escueta, A., Ellison, G.D. and Olsen, R.W. 1998. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 18:8505-8514. (Pubitemid 28465025)
31. DeMyer, M.K., Hingtgen, J.N. and Jackson, R.K. 1981. Infantile autism reviewed: a decade of research. Schizophr. Bull. 7:388-451. (Pubitemid 11025914)
32. Denney, D.R., Frei, B.W. and Gafney, G.R. 1996. Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 26:87-97. (Pubitemid 126738401)
33. Elchaar, G.M., Maisch, N.M., Augusto, L.M. and Wehring, H.J. 2006. Efcacy and safety of naltrexone use in pediatric patients with autistic disorder. Ann. Pharmacother. 40:1086-1095. (Pubitemid 43886966)
34. Evans, C., Dunstan, R.H., Rothkirch, T., Roberts, T.K., Reichelt, K.L., Cosford, R., Deed, G., Ellis, L.B. and Sparkes, D.L. 2008. Altered amino acid excretion in children with autism. Nutr. Neurosci. 11:9-17. (Pubitemid 351864128)
35. Feldman, H.M., Kolmen, B.K. and Gonzaga, A.M. 1999. Naltrexone and com-munication skills in young children with autism. J. Am. Acad. Child Adolesc. Psychiatry. 38:587-593. (Pubitemid 29203475)
36. Filipek, P.A., Juranek, J., Nguyen, M.T., Cummings, C. and Gargus, J.J. 2004. Relative carnitine defciency in autism. J. Autism Dev. Disord. 34:615-623.
37. Fuchs, D., Weiss, G. and Wachter, H. 1993. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int. Arch. Allergy Immunol. 101:1-6. (Pubitemid 23179069)
38. Galli-Carminati, G., Deriaz, N. and Bertschy, G. 2009. Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study. Swiss Med. Wkly. 139:293-296.
39. Geier, D.A. and Geier, M.R. 2006a. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox. Res. 10:57-64.
40. Geier, D.A. and Geier, M.R. 2006b. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 66:182-188. (Pubitemid 44413279)
41. Geier, D.A., Kern, J.K., Garver, C.R., Adams, J.B., Audhya, T., Nataf, R. and Geier, M.R. 2009. Biomarkers of environmental toxicity and susceptibility in autism. J. Neurol. Sci. 280:101-108.
42. Giannotti, F., Cortesi, F., Cerquiglini, A. and Bernabei, P. 2006. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J. Autism Dev. Disord. 36:741-752. (Pubitemid 44284978)
43. Gillberg, C. 1995. Endogenous opioids and opiate antagonists in autism: brief review of empirical fndings and implications for clinicians. Dev. Med. Child Neurol. 37:239-245.
44. Glickman, G. 2010. Circadian rhythms and sleep in children with autism. Neurosci Biobehav. Rev. 34:755-768.
45. Grigorenko, E.L., Han, S.S., Yrigollen, C.M., Leng, L., Mizue, Y., Anderson, G.M., Mulder, E.J., de Bildt, A., Minderaa, R.B., Volkmar, F.R., Chang, J.T. and Bucala, R. 2008. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics. 122:e438-e445.
46. Hardan, A.Y. and Handen, B.L. 2002. A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. J. Child Adolesc. Psychopharmacol. 12:237-241. (Pubitemid 35191350)
47. Hare, DJ., Jones, S. and Evershed, K. 2006. A comparative study of circadian rhythm functioning and sleep in people with Asperger syndrome. Autism. 10:565-575. (Pubitemid 44605442)
48. Hashimoto, K., Iwata, Y, Nakamura, K., Tsujii, M., Tsuchiya, KJ., Sekine, Y., Suzuki, K., Minabe, Y, Takei, N., Iyo, M. and Mori, N. 2006. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry. 30: 1529-1531. (Pubitemid 44634961)
49. Hohmann, C.F. and Berger-Sweeney, J. 1998. Cholinergic regulation of corti-cal development and plasticity. New twists to an old story. Perspect. Dev. Neurobiol. 5:401-425. (Pubitemid 29156522)
50. Hollander, E., DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cartwright, C., DeCaria, C.M., Kwon, J., Cunningham-Rundles, C., Chapman, F. and Zabriskie, J.B. 1999. B lymphocyte antigen D8/17 and repetitive behaviors in autism. Am. J. Psychiatry. 156:317-320. (Pubitemid 29077127)
51. Holmes, C., El-Okl, M., Williams, A.L., Cunningham, C., Wilcockson, D. and Perry, VH. 2003. Systemic infection, interleukin 1beta, and cog-nitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 74:788-789. (Pubitemid 36628295)
52. Horvath, K., Papadimitriou, J.C., Rabsztyn, A., Drachenberg, C. and Tildon, J.T. 1999. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135:559-563. (Pubitemid 30180444)
53. Horvath, K. and Perman, J.A. 2002. Autistic disorder and gastrointestinal dis-ease. Curr. Opin. Pediatr. 14:583-587.
54. Hoshino, Y., Kumashiro, H., Yashima, Y., Kaneko, M., Numata, Y., Oshima, N. and Watanabe, A. 1980. Plasma cyclic AMP level in psychiatric diseases of childhood. Folia Psychiatr. Neurol. Jpn. 34:9-16. (Pubitemid 10042568)
55. Hoshino, Y., Kumashiro, H., Yashima, Y., Tachibana, R., Watanabe, M. and Furukawa, H. 1982. Early symptoms of autistic children and its diagnostic signifcance. Folia Psychiatr. Neurol. Jpn. 36:367-374. (Pubitemid 13126312)
56. Hunter, L.C., O'Hare, A., Herron, W.J., Fisher, L.A. and Jones, G.E. 2003. Opioid peptides and dipeptidyl peptidase in autism. Dev. Med. Child Neurol. 45:121-128. (Pubitemid 36798209)
57. Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C., Leboyer, M. and Bourgeron, T.; Paris Autism Research International Sibpair (PARIS) Study. 2002. Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry. 7:302-310. (Pubitemid 34280638)
58. James, S.J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D.W. and Neubrander, J.A. 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80:1611-1617. (Pubitemid 41103861)
59. Jepson B. (Ed.) 2007a. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 176-180.
60. Jepson B. (Ed.) 2007b. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 225.
61. Jepson B. (Ed.) 2007c. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 226.
62. Jepson B. (Ed.) 2007d. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 227.
63. Jyonouchi, H., Sun, S. and Le, H. 2001. Proinfammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120:170-179. (Pubitemid 33016737)
64. Kaplan, D.R. and Miller, F.D. 2000. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:381-391. (Pubitemid 30389307)
65. Kaufman, S. 1986. Te metabolic role of tetrahydrobiopterin. In: Chemistry and Biology of Pteridines (Cooper, B.A. and Whitehead, V.A., Eds.), Berlin: Walter de Gruyter, pp. 185-200.
66. Kelley, D.J., Bhattacharyya, A., Lahvis, G.P., Yin, J.C., Malter, J. and Davidson, R.J. 2008. Te cyclic AMP phenotype of Fragile X and autism. Neurosci Biobehav. Rev. 32:1533-1543.
67. Kelley, R.I. and Hennekam, R.C. 2000. Smith-Lemli-Opitz syndrome. In: Te Metabolic and Molecular Basics of Inherited Disease, 8th Edit. (Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D., Eds.), New York: McGraw-Hill, pp. 6183-6201.
68. Kemper, T.L. and Bauman, M. 1998. Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 57:645-652. (Pubitemid 28335053)
69. Kitay, J.L. and Altschule, M.P. (Eds.) 1954. Te Pineal Gland. Cambridge, MA: Harvard Univ. Press, pp. 72-74.
70. Klauck, S.M., Poustka, F., Benner, A., Lesch, K.P and Poustka, A. 1997. Serotonin transporter (5-HTT) gene variants associated with autism? Hum. Mol Genet. 6:2233-2238. (Pubitemid 27501073)
71. Knickmeyer, R., Baron-Cohen, S., Raggatt, P. and Taylor, K. 2005. Foetal testo-sterone, social relationships, and restricted interests in children. J. Child Psychol. Psychiatry. 46:198-210. (Pubitemid 40425424)
72. Köhler, M., Assmann, B., Bräutigam, C., Storm, W., Marie, S., Vincent, M.F., Van den Berghe, G., Simmonds, H.A. and Hofmann, G.F. 1999. Adenylosuccinase defciency: possibly underdiagnosed encephalopathy with variable clinical features. Eur. J. Paediatr. Neurol. 3:3-6. (Pubitemid 29092959)
73. Kolvin, I. 1971. Studies in the childhood psychoses. I. Diagnostic criteria and classifcation. Br. J. Psychiatry. 118:381-384.
74. Koukkari, W.L. and Sothern, R.B. (Eds.) 2006. Introducing Biological Rhythms. New York: Springer pp. 1-18.
75. Kulman, G., Lissoni, P, Rovelli, F., Roselli, M.G., Brivio, F. and Sequeri, P. 2000. Evidence of pineal endocrine hypofunction in autistic children. Neuro Endocrinol. Lett. 21:31-34. (Pubitemid 30113676)
76. Kunkel, S.L., Ward, PA., Caporale, L.H. and Vogel, C.W. 1985. Te Complement System In: Immunology III (Bellanti, J. A., Ed.). Philadelphia: W.B. Saunders Co., pp. 106-116.
77. Laurie, DJ., Wisden, W. and Seeburg, PH. 1992. Te distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and post-natal development. J. Neurosci. 12:4151-4172.
78. Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., Feingold, J., Mouren-Simeoni, M.C. and Launay, J.M. 1999. Whole blood serotonin and plasma beta-endorphin in autistic probands and their frst-degree relatives. Biol. Psychiatry. 45:158-163. (Pubitemid 29079445)
79. Lee, M., Martin-Ruiz, C., Graham, A., Court, J., Jaros, E., Perry, R., Iversen, P, Bauman, M. and Perry, E. 2002. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain. 125:1483-1495. (Pubitemid 34755164)
80. Lerner, A.B., Case, J.D., Takahashi, Y., Lee, T.H. and Mori, W. 1958. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 80:2587.
81. Lerner, A.B., Case, J.D. and Takahashi, Y. 1960. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem. 235:1992-1997.
82. Lord, C., Rutter, M. and Le Couteur, A. 1994. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of indi-viduals with possible pervasive developmental disorders. J. Autism Dev. Disord. 24:659-685. (Pubitemid 24309810)
83. Luboshitzky, R., Wagner, O., Lavi, S., Herer, P. and Lavie, P. 1996. Decreased nocturnal melatonin secretion in patients with Klinefelter's syndrome. Clin. Endocrinol. (Oxf). 45:749-754. (Pubitemid 27032322)
84. Luboshitzky, R., Wagner, O., Lavi, S., Herer, P. and Lavie, P. 1997. Abnormal melatonin secretion in hypogonadal men: the efect of testosterone treatment. Clin. Endocrinol. (Oxf). 47:463-469. (Pubitemid 27452066)
85. Lucki, I. 1998. Te spectrum of behaviors infuenced by serotonin. Biol. Psychiatry. 44:151-162.
86. Malhotra, S., Sawhney, G. and Pandhi, P. 2004. Te therapeutic potential of melatonin: a review of the science. MedGenMed. 6:46.
87. Malow, B.A., Marzec, M.L., McGrew, S.G., Wang, L., Henderson, L.M. and Stone, W.L. 2006. Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep. 29:1563-1571. (Pubitemid 44936465)
88. Marinovic-Curin, J., Marinovic-Terzic, I., Bujas-Petkovic, Z., Zekan, L., Skrabic, V, Dogas, Z. and Terzic, J. 2008. Slower cortisol response during ACTH stimulation test in autistic children. Eur. Child Adolesc. Psychiatry. 17:39-43. (Pubitemid 351202150)
89. Martineau, J., Barthélémy, C., Jouve, J., Muh, J.P and Lelord, G. 1992. Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug efects. Dev. Med. Child Neurol. 34:593-603.
90. Martin-Ruiz, C.M., Lee, M., Perry, R.H., Baumann, M., Court, J.A. and Perry, E.K. 2004. Molecular analysis of nicotinic receptor expression in autism. Brain Res. Mol. Brain Res. 123:81-90. (Pubitemid 38392067)
91. Megson, M.N. 2000. Is autism a G-alpha protein defect reversible with natural vitamin A? Med. Hypotheses. 54:979-983. (Pubitemid 30446940)
92. Mehl-Madrona, L. 2000. Autism: An overview. www.healing-arts.org/ children/autism-overview.htm.
93. Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I.C., Delorme, R., Chabane, N., Mouren-Simeoni, M.C., Fauchereau, F., Durand, C.M., Chevalier, F., Drouot, X., Collet, C., Launay, J.M., Leboyer, M., Gillberg, C. and Bourgeron, T. 2008. Abnormal melatonin synthesis in autism spec-trum disorders. Mol. Psychiatry. 13:90-98. (Pubitemid 350275181)
94. Messahel, S., Pheasant, A.E., Pall, H., Ahmed-Choudhury, J., Sungum-Paliwal, R.S. and Vostanis, P. 1998. Urinary levels of neopterin and biopterin in autism. Neurosci Lett. 241:17-20. (Pubitemid 28079023)
95. Miyashiro, K. and Eberwine, J. 2004. Fragile X syndrome: (What's) lost in trans-lation? Proc. Natl. Acad. Sci. U.S.A. 101:17329-17330. (Pubitemid 39657403)
96. Moreno, H., Borjas, L., Arrieta, A., Sáez, L., Prassad, A., Estévez, J. and Bonilla, E. 1992. [Clinical heterogeneity of the autistic syndrome: a study of 60 families]. Invest. Clin. 33:13-31.
97. Mössner, R. and Lesch, K.P 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12:249-271. (Pubitemid 29224829)
98. Muhle, R., Trentacoste, S.V. and Rapin, I. 2004. Te genetics of autism. Pediatrics. 113:e472-e486.
99. Nataf, R., Skorupka, C., Amet, L., Lam, A., Springbett, A. and Lathe, R. 2006. Porphyrinuria in childhood autistic disorder: implications for environ-mental toxicity. Toxicol. Appl. Pharmacol. 214:99-108.
100. Nelson, K.B., Grether, J.K., Croen, L.A., Dambrosia, J.M., Dickens, B.F., Jellife, L.L., Hansen, R.L. and Phillips, T.M. 2001. Neuropeptides and neuro-trophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49:597-606. (Pubitemid 32429787)
101. Nir, I., Meir, D., Zilber, N., Knobler, H., Hadjez, J. and Lerner, Y 1995. Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J. Autism Dev. Disord. 25:641-654. (Pubitemid 26006039)
102. Norman, A.W. and Litwach, G. (Eds.) 1987. Hormones. New York: Academic Press, Inc., pp. 711.
103. Ornitz, E.M., Ritvo, E.R. and Walter, R.D. 1965. Dreaming sleep in autistic and schizophrenic children. Am. J. Psychiatry. 122:419-424.
104. Ornitz, E.M. 1973. Childhood autism. A review of the clinical and experimental literature. Calif. Med. 118:21-47.
105. Panksepp, J. 1979. A neurochemical theory of autism. Trends Neurosci. 2:174-177. (Pubitemid 10115864)
106. Pennell, PB., Burdette, D.E., Ross, D.A., Henry, T.R., Albin, R.L., Sackellares, J.C. and Frey, K.A. 1999. Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia. 40:38-46. (Pubitemid 29031751)
107. Perry, E.K., Lee, M.L., Martin-Ruiz, C.M., Court, J.A., Volsen, S.G., Merrit, J., Folly, E., Iversen, P.E., Bauman, M.L., Perry, R.H. and Wenk, G.L. 2001. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry. 158:1058-1066. (Pubitemid 32623109)
108. Plioplys, A.V., Greaves, A., Kazemi, K. and Silverman, E. 1994. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology. 29:12-16.
109. Polleux, F. and Lauder, J.M. 2004. Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev. 10:303-317. (Pubitemid 40209463)
110. Posey, D.J., Stigler, K.A., Erickson, C.A. and McDougle, CJ. 2008. Antipsychotics in the treatment of autism. J. Clin. Invest. 118:6-14
111. Ratajczak, H.V 2010. Teoretical aspects.of autism: Causes-A review. J. Immunotoxicol. (submitted for publication).
112. Reichelt, K.L. and Liu, Y 1997. Presentation at Defeat Autism Now! Meeting, San Diego, CA. Sept 19-21.
113. Reichelt, K.L. and Knivsberg, A.M. 2003. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr. Neurosci. 6:19-28. (Pubitemid 36157527)
114. Reiter, R. J., and Robinson, J. (Eds.) 1995a. Melatonin. New York: Bantam Books pp. 22-23.
115. Reiter, R. J., and Robinson, J. (Eds.) 1995b. Melatonin. New York: Bantam Books, p. 3.
116. Reiter, R. J., and Robinson, J. (Eds.) 1995c. Melatonin. New York: Bantam Books pp. 3-12.
117. Reiter, RJ., Tan, D.X. and Fuentes-Broto, L. 2010. Melatonin: a multitasking molecule. Prog. Brain Res. 181:127-151.
118. Renzoni, E., Beltrami, V., Sestini, P, Pompella, A., Menchetti, G. and Zappella, M. 1995. Brief report: allergological evaluation of children with autism. J. Autism Dev. Disord. 25:327-333.
119. Riddle, M.A., Bernstein, G.A., Cook, E.H., Leonard, H.L., March, J.S. and Swanson, J.M. 1999. Anxiolytics, adrenergic agents, and naltrexone. J. Am. Acad. Child Adolesc. Psychiatry. 38:546-556. (Pubitemid 29203470)
120. Rolf, L.H., Haarmann, F.Y, Grotemeyer, K.H. and Kehrer, H. 1993. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand. 87:312-316. (Pubitemid 23134638)
121. Rubenstein, J.L. and Merzenich, M.M. 2003. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2:255-267. (Pubitemid 37345664)
122. Sabbagh, M.N., Reid, R.T., Corey-Bloom, J., Rao, T.S., Hansen, L.A., Alford, M., Masliah, E., Adem, A., Lloyd, G.K. and Tal, L.J. 1998. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J. Neural Transm. 105:709-717. (Pubitemid 28454521)
123. Sanchez de la Pena, S. 1993. Te feed-sideward of cephalo-adrenal immune interactions. Chronobiologia 20:1-52.
124. Selmaoui, B. and Touitou, Y. 2003. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three diferent 24-h cycles over six weeks. Life Sci. 73:3339-3349. (Pubitemid 37311375)
125. Serajee, F.J., Zhong, H., Nabi, R. and Huq, A.H. 2003. Te metabotropic gluta-mate receptor 8 gene at 7q31: partial duplication and possible association with autism. J. Med. Genet. 40:e42.
126. Shanahan, M.R., Venturini, A.J., Daiss, J.L. and Friedman, A.E. 2000. Peptide diagnostic markers for human disorders. European Patent Application. Ep 0 969 015 A2. 05 Jan.
127. Shattock, P. and Whiteley, P. 2002. Biochemical aspects in autism spectrum dis-orders: updating the opioid-excess theory and presenting new opportuni-ties for biomedical intervention. Expert Opin. Ter. Targets. 6:175-183. (Pubitemid 34477460)
128. Singh, VK., Warren, R.P, Odell, J.D. and Cole, P. 1991. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin. Immunol. Immunopathol. 61:448-455.
129. Singh, VK., Warren, R.P, Odell, J.D., Warren, W.L. and Cole, P. 1993. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7:97-103. (Pubitemid 23227066)
130. Singh, VK. 1996. Plasma increase of interleukin-12 and interferon-gamma. Pathological signifcance in autism. J. Neuroimmunol. 66:143-145.
131. Singh, V.K., Warren, R., Averett, R. and Ghaziuddin, M. 1997. Circulating autoantibodies to neuronal and glial flament proteins in autism. Pediatr. Neurol. 17:88-90. (Pubitemid 27387929)
132. Slauson, D.O., Walker, C., Kristensen, F., Wang, Y. and de Weck, A.L. 1984. Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell. Immunol. 84:240-252. (Pubitemid 14173429)
133. Stefulj, J., Cicin-Sain, L., Schauenstein, K. and Jernej, B. 2001. Serotonin and immune response: efect of the amine on in vitro proliferation of rat lym-phocytes. Neuroimmunomodulation. 9:103-108. (Pubitemid 32830599)
134. Stubbs, E.G. and Crawford, M.L. 1977. Depressed lymphocyte responsiveness in autistic children. J. Autism Child. Schizophr. 7:49-55. (Pubitemid 8081956)
135. Sweeten, TL., Posey, D.J. and McDougle, C.J. 2003. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry. 160:1691-1693. (Pubitemid 41079558)
136. Tierney, E., Nwokoro, N.A., Porter, F.D., Freund, L.S., Ghuman, J.K. and Kelley, R.I. 2001. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 98:191-200. (Pubitemid 32051809)
137. Tint, G.S., Irons, M., Elias, E.R., Batta, A.K., Frieden, R., Chen, T.S. and Salen, G. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330:107-113.
138. Tordjman, S., Anderson, G.M., McBride, P.A., Hertzig, M.E., Snow, M.E., Hall, L.M., Ferrari, P. and Cohen, DJ. 1995. Plasma androgens in autism. J. Autism Dev. Disord. 25:295-304.
139. Tordjman, S., Anderson, G.M., McBride, P.A., Hertzig, M.E., Snow, M.E., Hall, L.M., Tompson, S.M., Ferrari, P. and Cohen, DJ. 1997. Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J. Child Psychol. Psychiatry. 38:705-715. (Pubitemid 27437736)
140. Tordjman, S., Antoine, C., Cohen, DJ., Gauvain-Piquard, A., Carlier, M., Roubertoux, P. and Ferrari, P. 1999. [Study of the relationships between self-injurious behavior and pain reactivity in infantile autism]. Encephale. 25:122-134. (Pubitemid 29249892)
141. Tordjman, S., Anderson, G.M., Pichard, N., Charbuy, H. and Touitou, Y. 2005. Nocturnal excretion of 6-sulphatoxymelatonin in children and adoles-cents with autistic disorder. Biol. Psychiatry. 57:134-138. (Pubitemid 40094713)
142. Tordjman, S., Anderson, G.M., Botbol, M., Brailly-Tabard, S., Perez-Diaz, F., Graignic, R., Carlier, M., Schmit, G., Rolland, A.C., Bonnot, O., Trabado, S., Roubertoux, P. and Bronsard, G. 2009. Pain reactivity and plasma ß-endorphin in children and adolescents with autistic disorder. PLoS ONE 4(8):e5289, doi:10.1371/journal.pone.0005289.
143. Vancassel, S., Durand, G., Barthélémy, C., Lejeune, B., Martineau, J., Guilloteau, D., Andrès, C. and Chalon, S. 2001. Plasma fatty acid levels in autistic chil-dren. Prostaglandins Leukot. Essent. Fatty Acids 65:1-7. (Pubitemid 32783435)
144. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W. and Pardo, C.A. 2005. Neuroglial activation and neuroinfammation in the brain of patients with autism. Ann. Neurol. 57:67-81. (Pubitemid 40053317)
145. Vojdani, A., Bazargan, M., Vojdani, E., Samadi, J., Nourian, A.A., Eghbalieh, N. and Cooper, E.L. 2004a. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin. Diagn. Lab. Immunol. 11:515-524. (Pubitemid 38661417)
146. Vojdani, A., O'Bryan, T., Green, J.A., Mccandless, J., Woeller, K.N., Vojdani, E., Nourian, A.A. and Cooper, E.L. 2004b. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci. 7:151-161. (Pubitemid 39307126)
147. Volkmar, F.R., Lord, C., Bailey, A., Schultz, R.T. and Klin, A. 2004. Autism and pervasive developmental disorders. J. Child Psychol. Psychiatry 45:135-170. (Pubitemid 38196258)
148. Volkmar, F. R., and Klin, A. 2005. Issues in the classifcation of autism and related conditions In: Handbook of Autism and Pervasive Developmental Disorders, 3rd Edition. (Volkmar, F.R., Paul, R., Klin, A., Cohen, D., Eds.), Hoboken, NJ: John Wiley & Sons, Inc., pp. 5-14.
149. Wakefeld, AJ., Murch, S.H., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, M., Dhillon, A.P, Tomson, M.A., Harvey, P, Valentine, A., Davies, S.E. and Walker-Smith, J.A. 1998. Ileal-lymphoid-nodular hyperplasia, non-specifc colitis, and pervasive developmental disorder in children. Lancet 351:637-641. (Pubitemid 28098447)
150. Ward, N.L. and Hagg, T. 2000. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp. Neurol. 162:297-310. (Pubitemid 30217725)
151. Waring, R. H., Ngong, J. M., Klovarza, L., Green, S., and Sharp, H. 1997. Biochemical parameters in autistic children. Dev. Brain Dysfunc. 10:40-43. (Pubitemid 27085429)
152. Waring, R. H., and Klovrza, L. V 2000. Sulfur metabolism in autism. J. Nutr Environ. Med. 10:25-32.
153. Warren, R.P, Margaretten, N.C., Pace, N.C. and Foster, A. 1986. Immune abnor-malities in patients with autism. J. Autism Dev. Disord. 16:189-197.
154. Warren, R.P, Foster, A. and Margaretten, N.C. 1987. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26:333-335. (Pubitemid 17116696)
155. +) T-cells in autism. Immunol. Invest. 19:245-251. (Pubitemid 20212230)
156. Warren, R.P., Singh, V.K., Cole, P, Odell, J.D., Pingree, C.B., Warren, W.L. and White, E. 1991. Increased frequency of the null allele at the complement C4b locus in autism. Clin. Exp. Immunol. 83:438-440.
157. Warren, R.P., Burger, R.A., Odell, D., Torres, A.R. and Warren, W.L. 1994. Decreased plasma concentrations of the C4B complement protein in autism. Arch. Pediatr. Adolesc. Med. 148:180-183. (Pubitemid 24071389)
158. Warren, R.P., Yonk, J., Burger, R.W., Odell, D. and Warren, W.L. 1995. DR-positive T-cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31:53-57.
159. Warren, R.P, Singh, V.K., Averett, R.E., Odell, J.D., Maciulis, A., Burger, R.A., Daniels, W.W. and Warren, W.L. 1996. Immunogenetic studies in autism and related disorders. Mol. Chem. Neuropathol. 28:77-81. (Pubitemid 26275053)
160. Warren, R.P, Odell, J.D., Warren, W.L., Burger, R.A., Maciulis, A., Daniels, W.W. and Torres, A.R. 1997. Brief report: immunoglobulin A defciency in a subset of autistic subjects. J. Autism Dev. Disord. 27:187-192. (Pubitemid 27157493)
161. Weizman, A., Weizman, R., Szekely, G.A., Wijsenbeek, H. and Livni, E. 1982. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am. J. Psychiatry. 139:1462-1465. (Pubitemid 12006206)
162. Werner, E.R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G. and Wachter, H. 1989. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by
163. Whitaker-Azmitia, PM. 2001. Serotonin and brain development: Role in human developmental diseases. Brain Res. Bull. 56:479-485 (Pubitemid 34031783)
164. Wikipedia. 2010. Available at http://en.wikipedia.org/'wiki/Interior- olivary-nucleus.
165. Willemsen-Swinkels, S.H., Buitelaar, J.K., Nijhof, G.J. and van England, H. 1995. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Arch. Gen. Psychiatry 52:766-773.
166. rd Ed. (Volkmar, F.R., Paul, R., Klin, A., and Cohen, D., Eds.) Hoboken, NJ: Wiley, pp. 583-605.
167. Wirojanan, J., Jacquemont, S., Diaz, R., Bacalman, S., Anders, T.F., Hagerman, RJ. and Goodlin-Jones, B.L. 2009. Te efcacy of melatonin for sleep problems in children with autism, Fragile X syndrome, or autism and Fragile X syndrome. J. Clin. Sleep Med. 5:145-150.
168. + helper T-cell depression in autism. Immunol. Lett. 25:341-345.
169. Young, M.R. and Matthews, J.P. 1995. Serotonin regulation of T-cell sub-populations and of macrophage accessory function. Immunology 84: 148-152.